Evaluation of the novel neuroprotective agent BW619C89 in the middle cerebral artery occlusion model of focal ischemia in the spontaneously hypertensive rat and normotensive Fischer 344 rat.
D000818:Animals; D002421:Caudate Nucleus / Q000187:drug effects / Q000473:pathology; D002536:Cerebral Arteries; D002544:Cerebral Infarction / Q000473:pathology / Q000517:prevention & control*; D006624:Hippocampus / Q000187:drug effects / Q000473:pathology; D002546:Ischemic Attack, Transient / Q000473:pathology / Q000517:prevention & control*; D018696:Neuroprotective Agents / Q000494:pharmacology*; D010879:Piperazines / Q000494:pharmacology*; D011743:Pyrimidines / Q000494:pharmacology*; D051381:Rats; D011916:Rats, Inbred F344; D011918:Rats, Inbred SHR; D013045:Species Specificity
D018696:Neuroprotective Agents; D010879:Piperazines; D011743:Pyrimidines; C081980:sipatrigine